Anupam Rasayan India has announced the signing of a six-year chemical supply contract with a global major specialty metal manufacturer headquartered in the United States. According to reports from CNBC TV18, this partnership represents a strategic expansion into a new segment for the company. The agreement involves the supply of a specialty chemical product specifically designed to support the customer's global operations. As per CNBC TV18, the company was awarded the order by a major specialty metal manufacturer headquartered in the US, though the company has not disclosed the financial considerations of this transaction, with the consideration value linked to quantities and deliveries undertaken over the course of the arrangement.
As reported by CNBC TV18, dispatches are expected to commence from the latter half of Q3 2027. This timeline provides the company with adequate preparation time to establish the necessary infrastructure and supply chain capabilities for this new customer relationship. The agreement represents a significant milestone in Anupam Rasayan's diversification strategy into specialized chemical manufacturing for international markets. According to CNBC TV18, the supplies are expected to be made over a multi-year period, with both companies viewing this as the beginning of a long-term relationship.
Anand Desai, Managing Director of Anupam Rasayan, expressed confidence in the partnership's potential, stating that "With the supplies under this contract spread over six-year period, both companies see this as the beginning of a long-term relationship. We are confident that our manufacturing expertise, quality standards and reliability will help us build lasting trust with our partner and we look forward to a strong and enduring partnership in the years ahead." As reported by CNBC TV18, the company expects this relationship to be mutually beneficial, leveraging their manufacturing capabilities and quality standards to establish trust with the international partner.
According to CNBC TV18, Anupam Rasayan reported mixed earnings for the June quarter, with strong annual growth in revenue and profit despite margin pressures. The company's net profit increased 14% to ₹38.6 crore from ₹34 crore in the first quarter last year. Revenue increased 35% to ₹655 crore from ₹485.8 crore in the previous fiscal. However, the company's EBITDA margin contracted to 24.8% from 25.6% in the year-ago period, while EBITDA increased 31% to ₹162.4 crore from ₹124.3 crore. The growth is largely volume-driven, with the pharma and polymer business continuing to support performance, as noted by the company's deputy CFO Vishal Thakkar to CNBC TV18.
As reported by CNBC TV18, shares of Anupam Rasayan India ended the previous session 0.5% lower at ₹1,234 apiece. The stock has gained 1.6% in the past month but is down 7% this year so far. Despite the recent decline, the company has raised its consolidated revenue growth guidance to over 30% in the current fiscal from its previous 20-25%. This upward revision reflects the company's strong performance and optimistic outlook, supported by the new six-year contract with the US specialty metal manufacturer.
